A Comparative Study on the Efficacy of Advanced PRF (A-PRF) versus Standard PRF (S-PRF) in treating Chronic Wounds, An Open-Label, Randomized Controlled Trial

Dr Ranganath V S0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年8月19日

试验速览

暂无简介。

•Participants with chronic wound for more than six weeks and have failed to heal by conventional treatments.
•Wound size of less than 20cm2.
•Both male and female participants.
•Age 20 years or older.
•Have a normal platelet count in range of 1,50,000- 4,50,000 cells/mm3.
•Have a normal PT time: 11- 16 seconds.
•Ability to provide informed consent or have a legally authorized representative able to provide consent on behalf of the participant.
•Willingness to comply with study procedures and follow-up visits.
•Adequate understanding of the study requirements and ability to communicate with study personnel.

•Presence of an active infection at the ulcer site.
•Patients on anticoagulants (warfarin, heparin).
•Pregnant and lactating women.
•Patients suffering from leukaemia, septicaemia, impaired platelet function or other haematological disorders.
•Patients with hypoproteinaemia.
•Patients taking long term steroid containing drugs or using steroid ointments on wounds.

发起方

Dr Ranganath V S